Hepatitis E virus infection among solid organ transplant recipients, the Netherlands

Emerging Infectious Diseases

Volumn 18, Issue 5, 2012, Pages 869-872

  Pas, Suzan D ^a   de Man, Rob A ^a   Mulders, Claudia ^a   Balk, Aggie H M M ^a   van Hal, Peter T W ^a   Weimar, Willem ^a   Koopmans, Marion P G ^a   Osterhaus, Albert D M E ^a   van der Eijk, Annemiek A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HYPERTRANSAMINASEMIA; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; MOLECULAR SEQUENCE DATA; ORGAN TRANSPLANTATION; PHYLOGENY; VIRAL PROTEINS;

EID: 84859841971     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1805.111712     Document Type: Article

References (15)

1. Tavitian S, Peron JM, Huynh A, Mansuy JM, Ysebaert L, Huguet F, et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol. 2010;49:141-4. http://dx.doi.org/10.1016/j.jcv.2010.06.016
2. Sellier P, Mazeron MC, Tesse S, Badsi E, Evans J, Magnier JD, et al. Hepatitis E virus infection in HIV-infected patients with elevated serum transaminases levels. Virol J. 2011;8:171. http://dx.doi.org/10.1186/1743-422X-8-171
3. Borgen K, Herremans T, Duizer E, Vennema H, Rutjes S, Bosman A, et al. Non-travel related hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004-2006. BMC Infect Dis. 2008;8:61. http://dx.doi.org/10.1186/1471-2334-8-61
4. Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Kruger DH, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol. 2012;56:500-2. Epub 2011 Jul 26. http://dx.doi.org/10.1016/j.jhep.2011.06.021
5. Zhao C, Li Z, Yan B, Harrison TJ, Guo X, Zhang F, et al. Comparison of real-time fl uorescent RT-PCR and conventional RT-PCR for the detection of hepatitis E virus genotypes prevalent in China. J Med Virol. 2007;79:1966-73. http://dx.doi.org/10.1002/jmv.21040
6. Zhai L, Dai X, Meng J. Hepatitis E virus genotyping based on fulllength genome and partial genomic regions. Virus Res. 2006;120:57-69. http://dx.doi.org/10.1016/j.virusres.2006.01.013
7. Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2009;15:1225-8. http://dx.doi.org/10.1002/lt.21819
8. Buti M, Cabrera C, Jardi R, Castells L, Esteban R. Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? Liver Transpl. 2010;16:106-7, author reply 8. http://dx.doi.org/10.1002/lt.21925
9. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140:1481-9. http://dx.doi.org/10.1053/j.gastro.2011.02.050
10. Herremans M, Bakker J, Duizer E, Vennema H, Koopmans MP. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol. 2007;14:562-8. http://dx.doi.org/10.1128/CVI.00231-06
11. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010;82:799-805. http://dx.doi.org/10.1002/jmv.21656
12. Bouwknegt M, Engel B, Herremans MM, Widdowson MA, Worm HC, Koopmans MP, et al. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in the Netherlands. Epidemiol Infect. 2008;136:567-76. http://dx.doi.org/10.1017/S0950268807008941
13. Mansuy JM, Bendall R, Legrand-Abravanel F, Saune K, Miedouge M, Ellis V, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis. 2011;17:2309-12. http://dx.doi.org/10.3201/eid1712.110371
14. Baylis SA, Hanschmann KM, Blumel J, Nubling CM. Standardization of hepatitis E virus (HEV) nucleic acid amplifi cation technique- based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol. 2011;49:1234-9. http://dx.doi.org/10.1128/JCM.02578-10
15. Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology. 2011;141:1665-72. http://dx.doi.org/10.1053/j.gastro.2011.07.051